Search

Your search keyword '"Ullmann, Andrew J"' showing total 398 results

Search Constraints

Start Over You searched for: Author "Ullmann, Andrew J" Remove constraint Author: "Ullmann, Andrew J" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
398 results on '"Ullmann, Andrew J"'

Search Results

1. A global public health convention for the 21st century

2. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

5. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

6. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

8. The “Choosing Wisely” initiative in infectious diseases

9. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

10. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

13. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology

14. Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

17. Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

19. Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

21. Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

22. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation

26. Comparison of 2 studies of treatment of invasive aspergillosis

27. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

28. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)

29. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

31. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections

37. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation

38. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

39. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

45. Posaconazole concentrations in the central nervous system

47. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

Catalog

Books, media, physical & digital resources